SCHEMBL9757151

SCHEMBL9757151

C=C(c1cccc(OCc2ccc3sc(C(=O)O)c(C)c3c2)c1)c1ccc2ccc(Cl)cc2n1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 3/20 0.43
MAOB P27338 3/20 0.41
MAOA P21397 2/20 0.41
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
TBXAS1 P24557 1/20 0.38
NR4A1 P22736 1/20 0.38
NR4A3 Q92570 1/20 0.38
CYSLTR1 Q9Y271 2/20 0.37
CYSLTR2 Q9NS75 1/20 0.37
EDNRA P25101 1/20 0.37
MRGPRX4 Q96LA9 4/20 0.37
GPBAR1 Q8TDU6 1/20 0.37
MGLL Q99685 1/20 0.37
SMPD1 P17405 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9757147 0.90 EDNRA (0.42) NR4A2MAOBMAOARXRARXRB
SCHEMBL9757647 0.82 MAOB (0.34) NR4A2MAOBMAOACYSLTR1CYSLTR2
SCHEMBL9757078 0.82 CYSLTR1 (0.53) CYSLTR1CYSLTR2
SCHEMBL9757224 0.81 EDNRA (0.48) TBXAS1CYSLTR1EDNRAGPBAR1
SCHEMBL9757716 0.78 ALOX5AP (0.48) CYSLTR1CYSLTR2EDNRA
SCHEMBL9757150 0.76 CYSLTR1 (0.43) TBXAS1CYSLTR1CYSLTR2EDNRA
SCHEMBL9757206 0.74 NR4A2 (0.42) NR4A2MAOBMAOARXRARXRB
SCHEMBL9757076 0.71 ALOX5 (0.59) CYSLTR1CYSLTR2EDNRAGPBAR1
SCHEMBL9757075 0.71 ROCK1 (0.32) MAOBMAOA
SCHEMBL9757039 0.71 PSMB8 (0.46) NR4A2MAOBMAOARXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991019475-A2 QUINOLINYL-BENZOHETEROBICYCLIC DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D¿4? RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1991-12-26 WO claimed
US-5041453-A Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4 RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1991-08-20 US disclosed